“I believe that the future of healthcare is a personalized understanding of our microbiome, and uBiome is leading the way in providing this information to patients,” said Danielle Capalino, MSPH, RD
SAN FRANCISCO April 27, 2018
uBiome, the world’s leading microbial genomics company, announces the addition of Danielle Capalino to its Scientific Advisory Board. Ms. Capalino is a Manhattan-based certified dietitian and nutritionist who holds a Master of Science in Public Health (MSPH) from the Johns Hopkins Bloomberg School of Public Health, as well as a degree in brain and cognitive science from the Massachusetts Institute of Technology. uBiome is pleased to welcome the diet and gut health specialist to its Scientific Advisory Board, whose members include world-class scientists, renowned doctors, and health experts from around the nation.
“We are thrilled to have Ms. Capalino as part of our Scientific Advisory Board,” said Dr. Jessica Richman, PhD, co-founder and CEO of uBiome. “Her profound knowledge about nutritional health will help advance uBiome's mission to develop and translate the science of the microbiome in the context of gut conditions as it relates to diet, weight management, and other lifestyle conditions.”
An expert in digestive health, Ms. Capalino works closely with clients who suffer with a variety of digestive issues. With her extensive background and personalized approach, she uses nutritional coaching to guide individuals through a wide array of gastrointestinal disorders. Ms. Capalino previously published a diet plan book for improving gut health titled, “The Microbiome Diet Plan.” Recently, the prominent dietitian launched a FODMAP program, which teaches individuals about getting rid of FODMAPs in a 14-module video course. Learn more about Ms. Capalino at http://www.daniellecapalino.com.
“I believe that the future of healthcare is a personalized understanding of our microbiome, and uBiome is leading the way in providing this information to patients,” said Danielle Capalino, MSPH, RD “As a dietitian specializing in digestive health, my patients want to understand how what they eat affects their microbiome and uBiome is the platform that is helping us get there.”
Founded in 2012, uBiome is the world’s leading microbial genomics company, with a mission to explore important research questions and develop reliable, accurate products and services focused on the microbiome. uBiome is funded by Y Combinator, Andreessen Horowitz, and 8VC, as well as other leading investors, and has received widespread recognition including the CNN 10: Startups to Watch, the IVY Technology Award, CNN Future 30, and was named one of Fast Company’s Most Innovative Companies in Healthcare in 2016 and in Data Science in 2018.